Median Technologies

Disclosure of Total Number of Voting Rights and Number of Shares in the Capital as of March 31st, 2024

Regulatory News:

Median Technologies (Paris:ALMDT):

Total number of shares

18,404,608

Number of real voting rights*
(excluding treasury shares**)

18,338,930

Theoretical number of voting rights*
(including treasury shares**)

18,296,452

(*) Class E preference shares are non-voting
(**) pursuant to article 223-11 of the AMF’s General Regulations

About Median Technologies: Pioneering in innovative imaging solutions and services, Median Technologies harnesses cutting-edge AI to elevate the accuracy of early cancer diagnoses and cancer treatments. Median's offerings, including iCRO for medical image analysis and management in oncology trials and eyonis, AI/ML tech-based suite of software as medical devices (SaMD), empower biopharmaceutical entities and clinicians to advance patient care and expedite novel therapies. The French-based company, with a presence in the U.S. and China, is listed on the Euronext Growth market (ISIN: FR0011049824, ticker: ALMDT). Median is eligible for the French SME equity savings plan scheme (PEA-PME). For more information: www.mediantechnologies.com

View source version on businesswire.com: https://www.businesswire.com/news/home/20240410892832/en/

The Median Technologies Stock at the time of publication of the news with a fall of -8,04 % to 2,518EUR on Lang & Schwarz stock exchange (10. April 2024, 17:49 Uhr).